![]() ![]() Treatment with cytarabine may cause a "cytarabine syndrome" characterised by flu-like symptoms, skin rash and occasionally chest pain. Read more about ocular toxicities associated with high dose cytarabine Consider individual patient clinical factors (including organ dysfunction), pharmacokinetic and pharmacodynamic properties of anticancer drugs in the chosen regimen, recent published evidence and the availability of therapeutic drug monitoring when determining dose selection. There is limited evidence on dosing in this patient group due to a lack of randomised clinical trials and under reporting of data. In cases where PPI may be considered inappropriate, substitution with a H2 antagonist may be a suitable alternative at the discretion of the transplant physician.ĭrug dosing in obese patients undergoing conditioning chemotherapy in BMT Read more about preventing anti-cancer therapy induced nausea and vomitingĬonsider commencing a PPI on admission (or at the start of conditioning regimen) and continue throughout transplant.ĭue to profound and long lasting inhibition of gastric acid, avoid concomitant administration with drugs such as mycophenolate mofetil, posaconazole syrup or itraconazole capsules (Of note, PPI is allowed with posaconazole tablet formulation). How you have radiation therapy treatment.How you have anticancer medicine treatment.Fertility, sex, pregnancy and breastfeeding.Complementary and alternative medicines.Gastric and oesophageal adjuvant and neoadjuvant.Non small cell lung cancer - Advanced/metastatic.Non small cell lung cancer - Adjuvant/neoadjuvant. ![]() Genetic testing using cancer gene panels.Genetic testing for heritable pathogenic variants. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |